Insider selling
Traded Aug 25 · filed 1 day laterNot reported under a pre-arranged trading plan
Bristol Myers Squibb's SVP and Controller sold $34K of Bristol Myers Squibb shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 31, 2026
79 tracked managers disclosed the same change for Q2 2026. From a 13F filed Jul 31, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q1 2026 13F
785,736
594,936
−24.3%
Share count drives classification; reported value also moves with price
0.26%
Within the filing's reported positions, not the manager's total assets
79
For Q2 2026
Insider selling
Traded Aug 25 · filed 1 day laterNot reported under a pre-arranged trading plan
Bristol Myers Squibb's SVP and Controller sold $34K of Bristol Myers Squibb shares. The filing does not indicate a pre-arranged trading plan.
Fund moves
96 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
79 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.